Hydrea

🧾 Product Overview Table

🧬 Introduction

Hydrea 500mg, manufactured by Sarabhai Chemicals, contains Hydroxyurea — a potent oral chemotherapy agent widely used in the management of chronic myeloid leukemia (CML), sickle cell anemia, and certain head and neck cancers. It works by inhibiting DNA synthesis, thereby slowing or stopping the growth of abnormal cells.

Due to its oral form and tolerability, Hydrea has become a foundational medication in hematologic and oncologic treatment regimens. It is often used for long-term disease management, especially in regions with limited access to advanced therapies.

🎥 Educational Video Placeholder

⚠️ Watch: Understanding Hydroxyurea Treatment for CML & Sickle Cell Anemia

👩‍⚕️ Doctor’s Insight

Dr. Meera Prakash, Oncologist:
“Hydroxyurea remains one of the most accessible and effective treatments for CML and sickle cell anemia. Its oral administration and cost-effectiveness make it particularly important in developing healthcare systems. Close monitoring of blood counts is essential for safety.”

💉 Dosage & Administration Table

⚠️ Side Effects, Storage & Warnings

• 🚫 Common Side Effects: Nausea, loss of appetite, mouth ulcers, diarrhea
• ⛔️ Serious Risks: Bone marrow suppression, leukopenia, thrombocytopenia
• ❄️ Storage Instructions: Store below 25°C, away from children, moisture-free
• ⚠️ Warnings: Regular blood tests required; not advised during pregnancy unless directed

🌍 Global Availability

🔗 Related Indian Alternatives (Different Molecules in Same Category)

📚 External Medical References

• WHO Guidelines
• Drugs.com – Hydroxyurea
• NHS UK – Hydroxyurea Info

⛑️ Medical Disclaimer
This article is for informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Consult a licensed physician before use.